Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis

Liver

Volumn 22, Issue 2, 2002, Pages 159-165

  Herold, Christoph ^a   Ganslmayer, Marion ^a   Deynet, Christine ^a   Hahn, Eckhart G ^a   Schuppan, Detlef ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aminopyrine breath test; Child Pugh classification; Christensen score; Galactose elimination capacity; Indocyanine green clearance; Mayo score; Sorbitol clearance

Indexed keywords

ALBUMIN; AMINOPHENAZONE; BILIRUBIN; GALACTOSE; IMMUNOGLOBULIN M; INDOCYANINE GREEN; PROTHROMBIN; SORBITOL; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; ASCITES; BREATH ANALYSIS; CHOLESTASIS; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; MALE; MEDICAL INFORMATION; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; SCORING SYSTEM;

AMINOPYRINE; BILIRUBIN; BREATH TESTS; COLLAGEN TYPE III; FEMALE; GALACTOSE; HUMANS; IMMUNOGLOBULIN M; INDOCYANINE GREEN; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SORBITOL;

EID: 0036268111     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2002.01641.x     Document Type: Article

References (42)

1. Survival algorithms and outcome analysis in primary biliary cirrhosis
2. Primary biliary cirrhosis
3. Primary biliary cirrhosis
4. Serum assays for liver fibrosis
5. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: A comparison with the Mayo model
6. Type III procollagen peptide: A marker of disease activity and prognosis in primary biliary cirrhosis
7. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease
8. Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis
9. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis: Relation to clinical symptoms, liver histopathology and outcome
10. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model
11. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial
12. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability
13. Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
14. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
15. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
16. Quantitative liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity
17. Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C
18. The 30-minute aminopyrine breath test: Optimization of sampling times after intravenous administration of 14C-aminopyrine
19. Determination of the hepatic elimination capacity (Lm) of galactose by single injection
20. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow
21. Estimation of hepatic blood flow with indocyanine green
22. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score
23. 14C-aminopyrine breath test analysis and conventional biochemical tests as predictors of survival in cirrhosis
24. The relationship between conventional liver tests, quantitative function tests and histopathology in cirrhosis
25. Predicting outcome of paracetamol poisoning by using 14C aminopyrine breath test
26. Aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis
27. Non-invasive evaluation of portal-systemic shunting in man by D-Sorbitol bioavailability
28. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients
29. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis
30. Intrinsic hepatic clearance and Child-Turcotte classification of liver function in cirrhosis
31. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: Markers of fibrosis in primary biliary cirrhosis
32. Prediction of survival of patients with primary biliary cirrhosis. Examination of the Mayo Clinic model on a group of patients with known endpoint
33. Serial quantitative liver function tests in patients with primary biliary cirrhosis: A prospective long-term study
34. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
35. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models
36. Ursodeoxycholic acid for primary biliary cirrhosis: Lesson from the past - Issues for the future
37. Clinical studies with silymarin: Fibrosis progression is the endpoint
38. Ursodeooxycholic acid for primary biliary cirrhosis
39. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial
40. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
41. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
42. Ten year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis